FindTrial
Sign In

A study to compare the effectiveness of 10% KOH and 0.05% Tretinoin in children with Molluscum contagiosum

Comparative study of 10% Potassium hydroxide and 0.05% Tretinoin in treatment of Molluscum Contagiosum in children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/09/027859
Enrollment
40
Registered
2020-09-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: 10% KOH: After taking informed consent from parents or guardian, patients who satisfy the inclusion and exclusion criteria will be started on topical therapy with 10% KOH or 0.05% Treti

Sponsors

DRPSIMS RF
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All cases of Molluscum Contagiosum less than 12 years of age who are not willing to undergo mechanical removal.

Exclusion criteria

Exclusion criteria: 1 Giant Molluscum Contagiosum lesions of more than 3 centimeters size 2 Known hypersensitivity to 10% KOH or 0.05% Tretinoin

Design outcomes

Primary

MeasureTime frame
To evaluate the better drug between 10% KOH and 0.05% Tretinoin for the treatment of Molluscum Contagiosum in children depending upon the faster response and effective healing of the lesions. The percentage of healing of lesions is used to assess the comparative efficacy of two drugs.Timepoint: Baseline, 2weeks, 4weeks, 6weeks, 8weeks—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactDr Ruvva Soumya

Dr Pinnamaneni Siddartha institute of medical sciences and research foundation

hsamanthula@gmail.com9704669068

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026